The changing face of AIDS-related opportunism: Cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review

Mycopathologia

Volumn 148, Issue 2, 2000, Pages 73-78

  Manfredi, Roberto ^a   Pieri, Federica ^a   Pileri, Stefano ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

AIDS; Case reports; Cryptococcosis; HAART; Immune reconstitution; Pathomorphism

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033285989     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007156027134     Document Type: Article

References (24)

1. Clinical epidemiological study of 171 cases of cryptococcosis
2. Risk factors for cryptococcal meningitis in HIV-infected patients
3. Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons
4. HIV combination therapy: Partial immune restitution unmasking latent cryptococcal infection
5. HIV combination therapy: Immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy
6. Opportunistic infections occurring during highly active antiretroviral treatment
7. Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy
8. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997
9. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
10. New approaches to managing opportunistic infections
11. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
12. Recovery of the immune system with antiretroviral therapy. The end of opportunism?
13. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
14. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs
15. 4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment
16. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998
17. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
18. Restoration of the immune system with anti-retroviral therapy
19. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy
20. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
21. Focal mycobacterial lymphadenitis following the initiation of protease inhibitor therapy in patients with advanced HIV-1 disease
22. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy
23. Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response
24. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils